Advertisement

Topics

Afferent Corporation Company Profile

14:32 EDT 24th June 2018 | BioPortfolio

Afferent Corporation is pioneering the development of a new class of medical devices to treat chronic neurological dysfunction. Its lead technology enhances the function of mechanoreceptor cells involved in sensory perception as a means of restoring brain function following stroke, addressing complications resulting from diabetic neuropathy, and improving elderly balance. Building on this technology platform, Afferent aims to establish a leadership position in the emerging field of neurotherapeutic devices.

Location

275 Westminster Street, Suite500
Providence
Rhode Island
02903-3426
United States of America

Contact

Phone: 401.453.9933
Fax: 401.453.9915
Email: jason_harry@afferentcorp.com


News Articles [89 Associated News Articles listed on BioPortfolio]

Orion Corporation: Managers' transactions - Ari Lehtoranta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Ari Lehtoranta Orion Corporation has received the...

Orion Corporation: Managers' transactions - Liisa Hurme

ORION CORPORATION         MANAGERS' TRANSACTIONS 2nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Liisa Hurme Orion Corporation has received...

Orion Corporation: Managers' transactions - Timo Maasilta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Timo Maasilta Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Eija Ronkainen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST Orion Corporation: Managers' transactions - Eija Ronkainen Orion Corporation has received...

Orion Corporation: Managers' transactions - Mikael Silvennoinen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Mikael Silvennoinen Orio...

Orion Corporation: Managers' transactions - Sirpa Jalkanen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Sirpa Jalkanen Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Heikki Westerlund

ORION CORPORATION      MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Heikki Westerlund Orion Co...

Orion Corporation: Managers' transactions - Ylppö Jukka

ORION CORPORATION         MANAGERS' TRANSACTIONS 03 JANUARY 2018 at 15.10 EET              Orion Corporation: Managers' transactions - Ylppö Jukka Orio...

PubMed Articles [76 Associated PubMed Articles listed on BioPortfolio]

Exploring Behavioral Correlates of Afferent Inhibition.

(1) Background: Afferent inhibition is the attenuation of the muscle response evoked from transcranial magnetic stimulation (TMS) by a prior conditioning electrical stimulus to a peripheral nerve. It ...

Vagal afferent activation suppresses systemic inflammation via the splanchnic anti-inflammatory pathway.

Electrical stimulation of the vagus nerve (VNS) is a novel strategy used to treat inflammatory conditions. Therapeutic VNS activates both efferent and afferent fibers; however, the effects attributabl...

Sphingosine-1-phosphate selectively activates vagal afferent C-fiber subtype in guinea pig esophagus.

Activation and sensitization of visceral afferent nerves by inflammatory mediators play important roles in visceral nociception. Sphingosine-1-phosphate (S1P) is a lipid with intracellular and extrace...

Urothelial bladder afferent neurons in the rat are anatomically and neurochemically distinct from non-urothelial afferents.

There is mounting evidence underscoring a role for the urothelium in urinary bladder sensation. Previous functional studies have identified bladder primary afferents with mechanosensitive properties s...

Urethral afferent signalling: role of 5-HT paraneurons.

In this issue of Acta Physiologica, Kullmann et al. examined the morphology and potential role in sensory signaling of a different class of specialized cells in mouse urethral epithelium that express...

Clinical Trials [37 Associated Clinical Trials listed on BioPortfolio]

Role of the Posterior Parietal Cortex in the Processing of Sensory Information

Although the primary motor cortex is considered has the common final pathway of motor commands, it is influenced by several structures as, for example, the premotor cortex and the posterio...

Somatosensory Stimulation in Knee Osteoarthritis

Worldwide, 9.6% of men and 18% of women aged over 60 years suffer from osteoarthritis (OA), most of which involve the knee. Within the OA patient population, 80% of the OA patients have li...

Novel Portable Diagnostic Device for Automatic Detection of Relative Afferent Pupillary Defect

This study is to evaluate the ability of a newly designed device, Optic Nerve Glass (O-Glass) to detect relative afferent pupillary defect (RAPD). In this prospective observational study, ...

Mechanism of Action of Biofeedback Therapy

Biofeedback therapy improves bowel symptoms and anorectal function in patients with dyssynergic defecation, however its mechanism of action is not known. The investigators hypothesize that...

A European Trial to Assess the Efficacy of an Implantable Wireless Neuromodulation Device at the Tibial Nerve to Treat Urinary Urgency Incontinence

10 patient Study. All patients implanted with StimGuard Protect System. Patient followed out to 90 days.

Companies [177 Associated Companies listed on BioPortfolio]

Afferent Corporation

Afferent Corporation is pioneering the development of a new class of medical devices to treat chronic neurological dysfunction. Its lead technology enhances the function of mechanoreceptor cells invol...

Afferent Pharmaceuticals

Afferent Pharmaceuticals is focused on developing first-in-class medicines to treat chronic pain by targeting P2X3 receptors in nerve fibers. Research shows that P2X3-containin...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

More Information about "Afferent Corporation" on BioPortfolio

We have published hundreds of Afferent Corporation news stories on BioPortfolio along with dozens of Afferent Corporation Clinical Trials and PubMed Articles about Afferent Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Afferent Corporation Companies in our database. You can also find out about relevant Afferent Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...


Corporate Database Quicklinks



Searches Linking to this Company Record